Updating the Brazilian Pharmacopoeia

Anvisa’s Collegiate Board Resolution (RDC) 832, of December 11, 2023, updated the 6th edition of the Brazilian Pharmacopoeia, which came into force on January 2, 2024.

The companies have 180 days from the date the regulation comes into force to adapt their procedures. Read more here

If you need information and help with Strategic Advice for the Pharmaceutical, Health and Wellness Industry, ELS can certainly help with our services.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

Contact us

We will contact you as soon as possible.